Current Issue : October-December Volume : 2025 Issue Number : 4 Articles : 5 Articles
Temporal hollowing, which is a depression in the temple region, often results from trauma, surgical interventions, or neurological conditions. This condition is frequently observed after the resection of encephaloceles, where it can cause esthetic and functional challenges due to temporalis muscle atrophy and nerve palsy. We present a case of a 21-year-old female patient who developed temporal hollowing and complete atrophy of the right temporalis muscle following an encephalocele resection in childhood. The patient also suffered from right-sided frontal nerve branch palsy. To address this complex deformity, a patient-specific implant (PSI) made of hydroxyapatite (HA) was digitally designed and produced using 3D printing technology. The postoperative course was uneventful, with the implant securely positioned and the esthetic result highly satisfactory. This case highlights the potential of 3D printed PSIs in craniofacial reconstruction, offering an optimal solution for both functional restoration and esthetic enhancement. HA further ensures the long-term stability and integration of the implant, providing a promising approach for addressing complex craniofacial defects....
Introduction: Systemic immunosuppressive medication and targeted therapies (IMTT) can increase the risk of surgical procedures to patients. The risks of continuing their systemic IMTT medication during the pre- , peri- and post- operative period must be weighed up against the risk of stopping their medication. Currently, there is a paucity of evidence and national guidance on the management of oral surgery and oral and maxillofacial surgery patients taking IMTT. Materials and Methods: A cross- sectional online survey was distributed to clinicians within primary and secondary care who were providing oral surgery or oral and maxillofacial surgery services. Distribution was through the British Association of Oral Surgery (BAOS) and the British Association of Oral and Maxillofacial Surgery (BAOMS). The survey explored current practice and available guidance with regard to alteration of IMTT dosing intervals and contact with the prescribing clinician. Results: One hundred and forty- six surveys were completed by clinicians working in oral surgery or maxillofacial surgery settings, and general dental practitioners with a special interest in oral surgery. The majority of responses were collected from clinicians practising in the UK both in primary and secondary care. The results show that clinicians frequently treat patients taking IMTT. Currently, there are a variety of approaches to managing patients on IMTT and a lack of standardisation across the specialities. Conclusion: Further research and evidence- based national guidance, specifically for oral surgery and oral and maxillofacial surgery, would provide clarity on the optimal care for those taking IMTT....
Objective: Various orbital conditions (trauma, autoimmune thyroid disease, tumors, infections, congenital malformations) may lead to a consecutive increase in orbital cavity pressure resulting in orbital compartment syndrome (OCS). OCS is associated with acute loss of visual function and a high risk of permanent damage to the optic nerve (compressive optic neuropathy). Orbital decompression surgery (ODS) is a time-critical procedure that reduces pressure on the optic nerve, thereby improving visual function. The surgical management protocol for orbital decompression is not standardized and varies. Surgical techniques differ in orbital fat decompression, lateral canthotomy, and decompression of the medial orbital wall and floor. This retrospective study aims to evaluate surgery procedures and the outcome of visual function after orbital decompression surgery. Methods: In this retrospective study, we evaluated 28 patients (17 male, 11 female) with orbital compartment syndrome from May 2016 to October 2024. All patients underwent orbital decompression surgery as first-line treatment. Visual acuity (VA), diplopia, and ocular motility were analyzed pre- and postoperatively. Recovery was defined as postoperative improvement of vision, diplopia, and ocular motility. Linear and logistic regression analyses were used to assess the associations between clinically relevant risk factors and primary outcomes. Results: Orbital decompression surgery was performed with a median of 8.40 h (Q1: 4.80, Q3: 24.00) upon occurrence of symptoms. The average preoperative measured VA (logMAR) of the affected eye was 1.0. A total of 46% of the patients were preoperatively categorized as ”blind“ according to the WHO visual impairment categories. A total of 96% of the patients showed preoperative ocular motility impairment. Diplopia was preoperatively present in 46% of the patients. After orbital decompression surgery, postoperative visual acuity improved in 36% of the patients. Ocular motility improved by 67% and diplopia by 62% after ODS. The primary surgery technique was two-wall decompression in 68% (19/28) of the cases, followed by one-wall decompression (21%; 6/28), and three-wall decompression (11%; 3/28). Lateral decompression (82%; 23/28) and medial wall decompression (93%; 26/28) were the primary procedures performed. Orbital floor wall decompression was performed in only 14% (4/28) of the cases. Regression analysis revealed a statistically significant effect of preoperative measured vision on postoperative vision, while accounting for age, sex, and time to surgery. Conclusions: Orbital decompression surgery is the time-sensitive first-line treatment of acute visual function loss in OCS. Our data showed a postoperative improvement in visual acuity in 36% of the patients, along with considerable improvement rates in diplopia and ocular motility. The primary surgery technique was a two-wall decompression approach with lateral wall decompression and medial wall decompression. Center-specific timeline optimization of OCS patients is essential....
Background/Objectives: Significant weight loss, whether through bariatric surgery or medication-assisted approaches, presents unique challenges for body contouring procedures. A thorough preoperative evaluation is essential to optimize outcomes and minimize risks. Methods: A comprehensive literature search was conducted across various databases to identify studies on assessment, nutritional optimization, thromboembolic risk, and surgical planning for post-weight-loss patients, with a particular focus on those undergoing medication-assisted weight loss using Glucagon-like peptide-1 (GLP-1) agonists. Results: A detailed review of medical history, comorbidities, weight loss trajectory, and nutritional status is essential. Common conditions such as diabetes, hypertension, and sleep apnea often improve after weight loss but require ongoing management. Nutritional deficiencies, particularly in vitamins and minerals, necessitate dietary counseling and supplementation. Patients who have undergone significant weight loss are at increased risk of thromboembolic events, particularly after body contouring procedures. Surgical planning should be patient-centered, setting realistic expectations and employing a strategic, staged approach when necessary to optimize outcomes. GLP-1 agonists users require special consideration due to their distinct metabolic and physiological profiles. Conclusions: Optimizing preoperative assessment, nutrition, and thromboprophylaxis is critical for safe and effective body contouring in post-weight-loss patients. With the increasing prevalence of medication-assisted weight loss, surgical strategies must adapt to address the distinct anatomical and physiological features of these patients....
Background: Pharyngeal stenosis (PS) is a common sequela of a total laryngectomy (TL), and the most common cause of postoperative dysphagia. Its exact incidence is not known. A greater understanding of this clinical complication could serve to better inform patients considering a laryngectomy. Objective: Pharyngeal stenosis (PS) is a common sequela of a total laryngectomy (TL) and causes dysphagia. This systematic review aims to characterize PS as a sequela of a TL, specifically the incidence of dysphagia requiring dilation, and the frequency/timing of dilation interventions. Data Sources: We used PubMed. Review Methods: A search of all studies from PubMed published from conception to January 2024 was conducted. Cohort studies reporting PS requiring dilation following a TL were included. Data were collected on the incidence, recurrence, median time from TL to dilation, TL indication, and reconstructive approach. Two evaluators independently performed the study screening and data collection; all the differences were resolved by a third evaluator. Results: Eleven studies met the inclusion criteria. A total of 1421 patients underwent a TL, of which 659 (46.4%) were salvage, 286 (20.1%) were the primary treatment, and 153 (10.8%) were the primary with an adjuvant treatment. A total of 255 patients underwent reconstruction, among whom 86 (33.7%) had regional and 169 (66.3%) had free flaps. The mean age at the time of the TL was 64.1 (range 20–87) years, with a male-to-female ratio of 3.4:1. The overall incidence of dysphagia after a TL requiring dilation was 26%. Of the 370 patients who required dilation, 69.4% required multiple procedures. The median time to the first dilation post-TL ranged from 9 to 24 months. The overall complication rate was 4.3%, including perforation, infection, and diminished tracheoesophageal voice quality. Conclusions: Approximately one in four patients developed stenosis requiring dilation after a TL, of which two out of three required repeat dilations. Major complications, though rare, were predominantly observed during the first few dilation procedures....
Loading....